These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12783130)

  • 1. Association between levels of TNF-alpha and TNF-alpha promoter -308 A/A polymorphism in children with Kawasaki disease.
    Chien YH; Chang KW; Yang YH; Lu MY; Lin YT; Chiang BL
    J Formos Med Assoc; 2003 Mar; 102(3):147-50. PubMed ID: 12783130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].
    Yang J; Li CR; Li YB; Li RX; Sun LB; Huang HJ; Wang GB
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):598-602. PubMed ID: 14744383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea.
    Ahn SY; Jang GC; Shin JS; Shin KM; Kim DS
    Yonsei Med J; 2003 Dec; 44(6):1021-6. PubMed ID: 14703611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease.
    Kamizono S; Yamada A; Higuchi T; Kato H; Itoh K
    Pediatr Int; 1999 Aug; 41(4):341-5. PubMed ID: 10453180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease.
    Nishimura S; Zaitsu M; Hara M; Yokota G; Watanabe M; Ueda Y; Imayoshi M; Ishii E; Tasaki H; Hamasaki Y
    J Pediatr; 2003 Sep; 143(3):357-62. PubMed ID: 14517520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory polymorphism in promoter region of TNFR1 gene is associated with Kawasaki disease in Chinese individuals.
    Wang GB; Li CR; Yang J; Wen PQ; Jia SL
    Hum Immunol; 2011 May; 72(5):451-7. PubMed ID: 21315128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-inflammatory cytokine single nucleotide polymorphisms in Kawasaki disease.
    Assari R; Aghighi Y; Ziaee V; Sadr M; Rahmani F; Rezaei A; Sadr Z; Moradinejad MH; Raeeskarami SR; Rezaei N
    Int J Rheum Dis; 2018 May; 21(5):1120-1126. PubMed ID: 27455075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.
    Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T
    Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor -308 and lymphotoxin +252 polymorphisms in Mexican children with Kawasaki disease and coronary aneurysms.
    Cruz-Olivo F; García-Elorriaga G; González-Bonilla C; Del Rey-Pineda G; Mancilla-Ramírez J
    Arch Med Res; 2011 Oct; 42(7):602-7. PubMed ID: 22100609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease.
    Okada S; Hasegawa S; Suzuki Y; Matsubara T; Shimomura M; Okuda M; Ichiyama T; Ohga S
    Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
    Hong YM; Jin HS; Park IS; Hong SJ
    Heart Vessels; 2008 Sep; 23(5):341-7. PubMed ID: 18810583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory gene polymorphisms and susceptibility to kawasaki disease and its arterial sequelae.
    Cheung YF; Huang GY; Chen SB; Liu XQ; Xi L; Liang XC; Huang MR; Chen S; Huang LS; Liu XQ; Chan KW; Lau YL
    Pediatrics; 2008 Sep; 122(3):e608-14. PubMed ID: 18710885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease.
    Quasney MW; Bronstein DE; Cantor RM; Zhang Q; Stroupe C; Shike H; Bastian JF; Matsubara T; Fujiwara M; Akimoto K; Newburger JW; Burns JC
    Pediatr Res; 2001 May; 49(5):686-90. PubMed ID: 11328953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.
    Park JA; Shin KS; Kim YW
    J Korean Med Sci; 2005 Aug; 20(4):607-11. PubMed ID: 16100452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease.
    González S; Rodrigo L; Martínez-Borra J; López-Vázquez A; Fuentes D; Niño P; Cadahía V; Saro C; Dieguez MA; López-Larrea C
    Am J Gastroenterol; 2003 May; 98(5):1101-6. PubMed ID: 12809834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of interleukin 18 promoter polymorphisms in susceptibility to Kawasaki disease in Taiwan.
    Hsueh KC; Lin YJ; Chang JS; Wan L; Tsai YH; Tsai CH; Tsai FJ
    J Rheumatol; 2008 Jul; 35(7):1408-13. PubMed ID: 18484687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population.
    Nedoszytko B; Szczerkowska-Dobosz A; Zabłotna M; Gleń J; Rebała K; Roszkiewicz J
    Br J Dermatol; 2007 Jul; 157(1):165-7. PubMed ID: 17553030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.